eUltra 10k test for adults using the Biofreedom Ultra device
This trial studies a medical device called Biofreedom Ultra, using the study’s official instructions for safe use. If you’re an adult, you can join after giving consent, unless specific legal or pregnancy-related protections apply.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must sign a consent form to join the study
- You must meet the device’s current instructions for safe use (as listed in the study paperwork)
- You must not fall under exclusion rules related to pregnancy or breastfeeding (per study rules)
- You must not be under legal protections such as guardianship or curatorship, or be deprived of liberty
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called BF844 in healthy volunteers to see how safe it is and how the body processes it. Participants will take the drug and be monitored closely for side effects.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This study tests how a new medication called UI087 moves through your body and whether it's safe. Researchers will compare it to three other drugs given together to understand if combining them into one pill works better.
This study tests how well a new breast scanning device works in people who volunteer. You may be eligible if you can safely tolerate the scan and fit your breast into the device.
This study is testing how well a special ECMO device (Novalung ultimate kit with Xenios 2.0) works for adults in the hospital and during ground transport. If you already need ECMO with this specific device, you may be able to join.
This study tests whether a new medication called ERX1000 is safe and well-tolerated in adults with obesity. The trial will help doctors understand if this treatment could be helpful for weight management.
Hear when a new Post Market Clinical Follow up (PMCF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.